HTG Molecular Diagnostics Company Profile (NASDAQ:HTGM)

About HTG Molecular Diagnostics

HTG Molecular Diagnostics, Inc. is a commercial-stage company that develops and markets a technology platform to facilitate the routine use of complex molecular profiling. The Company's HTG Edge and HTG EdgeSeq platforms, consisting of instrumentation, consumables and software analytics, are used in sample profiling applications, including tumor profiling, molecular diagnostic testing and biomarker development. The Company's HTG Edge and HTG EdgeSeq platforms automate the molecular profiling of genes and gene activity using its nuclease protection chemistry on a range of biological samples. The Company's HTG EdgeSeq chemistry, together with its HTG Edge or HTG EdgeSeq instrumentation and software, automates and adapts its nuclease protection chemistry to enable analysis using next generation sequencing (NGS) instrumentation. The HTG EdgeSeq system utilizes substantially the same sample preparation reagents as its original chemistry, but allows for read out on an NGS instrument.

Industry, Sector and Symbol:

Sector: Medical
Industry: Medical Laboratories & Research
Sub-Industry: N/A
Exchange: NASDAQ
Symbol: HTGM
CUSIP:

Key Metrics:

Previous Close: $2.47
50 Day Moving Average: $2.46
200 Day Moving Average: $2.68
52-Week Range: $2.03 - $9.59
Trailing P/E Ratio: N/A
Foreward P/E Ratio: -0.93
P/E Growth: 0.00
Market Cap: $17.27M
Outstanding Shares: 7,050,000
Beta: 0.32

Additional Links:

Companies Related to HTG Molecular Diagnostics:

Consensus Ratings for HTG Molecular Diagnostics (NASDAQ:HTGM) (?)

Ratings Breakdown:	3 Buy Ratings
Consensus Rating:	Buy (Score: 3.00)
Consensus Price Target:	$5.33 (115.92% upside)

Analysts' Ratings History for HTG Molecular Diagnostics (NASDAQ:HTGM)

Show:

Date	Firm	Action	Rating	Price Target
8/22/2016	Rodman & Renshaw	Initiated Coverage	Buy	$5.00
5/13/2016	Canaccord Genuity	Reiterated Rating	Buy	$6.00
3/28/2016	Leerink Swann	Reiterated Rating	Outperform	$10.00 -> $5.00
6/3/2015	JMP Securities	Initiated Coverage	Outperform	$21.00

(Data available from 9/27/2014 forward)

Earnings History for HTG Molecular Diagnostics (NASDAQ:HTGM)

Date	Quarter	Consensus Estimate	Actual EPS	Revenue Estimate	Actual Revenue	Release Link	Conference Call
11/10/2016
8/9/2016	Q2	($0.95)	($0.98)			View	Listen
5/12/2016	Q1	($0.83)	($1.02)			View	Listen
3/24/2016	Q4	($0.79)	($0.83)		$1.20 million	View	Listen
11/12/2015	Q315	($0.85)	($0.76)	$1.07 million	$1.00 million	View	Listen
8/6/2015	Q215	($0.71)	($1.73)	$1.17 million		View	Listen
6/1/2015	Q115		($14.99)		$1.00 million	View	Listen

(Data available from 1/1/2011 forward)

Earnings Estimates for HTG Molecular Diagnostics (NASDAQ:HTGM)

Current Year EPS Consensus Estimate: $-3.58 EPS
Next Year EPS Consensus Estimate: $-2.66 EPS

Quarter	Number of Estimates	Low Estimate	High Estimate	Average Estimate
Q1 2016	2	($0.83)	($0.82)	($0.83)
Q2 2016	2	($0.86)	($0.84)	($0.85)
Q3 2016	2	($0.83)	($0.81)	($0.82)
Q4 2016	2	($0.84)	($0.80)	($0.82)

(Data provided by Zacks Investment Research)

Dividend History for HTG Molecular Diagnostics (NASDAQ:HTGM)
No dividend announcements for this company have been tracked by MarketBeat.com

Insider Trading History for HTG Molecular Diagnostics (NASDAQ:HTGM)

Transaction Date	Insider Name	Title	Buy/Sell	Number of Shares	Average Share Price	Total Transaction
4/4/2016	Debra A Gordon	VP	Sell	1,672	$2.89	$4,832.08
4/4/2016	John L Lubniewski	Insider	Sell	796	$2.89	$2,300.44
4/4/2016	Shaun D Mcmeans	CFO	Sell	1,601	$2.89	$4,626.89
4/4/2016	Tim B Johnson	CEO	Sell	4,914	$2.89	$14,201.46
3/14/2016	Debra A Gordon	VP	Sell	5,535	$2.38	$13,173.30
3/14/2016	John L Lubniewski	Insider	Sell	6,889	$2.38	$16,395.82
3/14/2016	Patrick C Roche	SVP	Sell	5,929	$2.38	$14,111.02
3/14/2016	Shaun D Mcmeans	CFO	Sell	5,651	$2.38	$13,449.38
3/14/2016	Tim B Johnson	CEO	Sell	10,621	$2.38	$25,277.98
3/9/2016	Debra A Gordon	VP	Sell	3,256	$2.69	$8,758.64
3/9/2016	John L Lubniewski	Insider	Sell	4,067	$2.69	$10,940.23
3/9/2016	Patrick C Roche	SVP	Sell	3,491	$2.69	$9,390.79
3/9/2016	Shaun D Mcmeans	CFO	Sell	3,325	$2.69	$8,944.25
3/9/2016	Tim B Johnson	CEO	Sell	6,299	$2.69	$16,944.31
8/24/2015	Debra A Gordon	VP	Buy	1,000	$5.16	$5,160.00
8/18/2015	Patrick C. Roche	SVP	Buy	6,500	$5.76	$37,440.00
8/11/2015	John L Lubniewski	Insider	Buy	5,000	$7.67	$38,350.00
5/11/2015	A/S Novo	Major Shareholder	Buy	365,106	$14.00	$5,111,484.00

(Data available from 1/1/2013 forward)

Latest Headlines for HTG Molecular Diagnostics (NASDAQ:HTGM)

Date	Headline
	ETF’s with exposure to HTG Molecular Diagnostics, Inc. : September 20, 2016 (NASDAQ:HTGM) www.capitalcube.com - September 20 at 10:38 AM
	HTG Molecular Diagnostics : Dr. Ann Hanham Joins HTG Molecular Diagnostics Board of Directors (NASDAQ:HTGM) www.4-traders.com - August 30 at 5:36 PM
	HTG MOLECULAR DIAGNOSTICS, INC Files SEC form 8-K, Change in Directors or Principal Officers, Submission of Matters t (NASDAQ:HTGM) biz.yahoo.com - August 30 at 5:36 PM
	BRIEF-Ann Hanham joins HTG Molecular Diagnostics' board (NASDAQ:HTGM) www.reuters.com - August 30 at 8:41 AM
	Dr. Ann Hanham Joins HTG Molecular Diagnostics’ Board of Directors (NASDAQ:HTGM) www.publicnow.com - August 29 at 5:23 PM
	ETF’s with exposure to HTG Molecular Diagnostics, Inc. : August 23, 2016 (NASDAQ:HTGM) www.capitalcube.com - August 23 at 5:42 PM
	HTG Molecular's Profiling System 'Requires Less But Delivers More' (NASDAQ:HTGM) finance.yahoo.com - August 22 at 5:36 PM
	Coverage initiated on HTG Molecular Diagnostics by Rodman & Renshaw (NASDAQ:HTGM) finance.yahoo.com - August 22 at 10:07 AM
	HTG MOLECULAR DIAGNOSTICS, INC : Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing (form 8-K) (NASDAQ:HTGM) www.4-traders.com - August 19 at 5:28 PM
	HTG MOLECULAR DIAGNOSTICS, INC Files SEC form 8-K, Notice of Delisting or Failure to Satisfy a Continued Listing Rule (NASDAQ:HTGM) biz.yahoo.com - August 19 at 5:28 PM
	HTG Molecular Diagnostics, Inc. :HTGM-US: Earnings Analysis: Q2, 2016 By the Numbers : August 12, 2016 (NASDAQ:HTGM) www.capitalcube.com - August 12 at 5:36 PM
	Edited Transcript of HTGM earnings conference call or presentation 9-Aug-16 8:30pm GMT (NASDAQ:HTGM) finance.yahoo.com - August 10 at 5:47 PM
	HTG Molecular Diagnostics Inc Earnings Call (Q2 2016) (NASDAQ:HTGM) biz.yahoo.com - August 9 at 4:21 PM
	HTG Molecular Diagnostics Reports Second Quarter 2016 Results (NASDAQ:HTGM) finance.yahoo.com - August 9 at 4:21 PM
	HTG Molecular Diagnostics Inc Earnings Call scheduled for 4:30 pm ET today (NASDAQ:HTGM) biz.yahoo.com - August 9 at 4:21 PM
	Q2 2016 HTG Molecular Diagnostics Inc Earnings Release - After Market Close (NASDAQ:HTGM) biz.yahoo.com - August 9 at 8:30 AM
	HTG Molecular Diagnostics to Hold 2016 Second Quarter Financial Results Conference Call on August 9 (NASDAQ:HTGM) www.nasdaq.com - July 29 at 8:26 AM
	HTG Molecular Diagnostics to Hold 2016 Second Quarter Financial Results Conference Call on August 9, 2016 (NASDAQ:HTGM) www.publicnow.com - July 28 at 4:28 PM
	HTG Molecular Diagnostics to Present at the Canaccord Genuity Growth Conference (NASDAQ:HTGM) www.publicnow.com - July 28 at 4:28 PM
	HTG Molecular Diagnostics : Obtains CE IVD Mark for Its HTG EdgeSeq DLBCL Cell of Origin Assay and HTG EdgeSeq System (NASDAQ:HTGM) www.4-traders.com - July 21 at 5:40 PM
	HTG Molecular Diagnostics Obtains CE IVD Mark for Its HTG EdgeSeq DLBCL Cell of Origin Assay and HTG EdgeSeq System (NASDAQ:HTGM) www.nasdaq.com - July 21 at 11:33 AM
	ETF’s with exposure to HTG Molecular Diagnostics, Inc. : July 20, 2016 (NASDAQ:HTGM) www.capitalcube.com - July 20 at 12:33 PM
	HTG Molecular Diagnostics and Firalis Announce Agreement to Develop a Theranostic Tool to Predict Response to Anti-TNF-alpha Therapies for Rheumatoid Arthritis (NASDAQ:HTGM) www.publicnow.com - July 6 at 4:11 PM
	Slone Partners Places VP of North American Capital Sales at HTG Molecular Diagnostics (NASDAQ:HTGM) www.ssuchronicle.com - June 25 at 9:21 AM
	HTG Molecular Diagnostics Announces VERI/O Laboratory Service (NASDAQ:HTGM) www.publicnow.com - June 23 at 4:19 PM
	HTG Molecular Diagnostics : Appoints New Vice President of North American Capital Sales for the HTG EdgeSeq Platform (NASDAQ:HTGM) www.4-traders.com - June 21 at 5:13 PM
	HTG Molecular Appoints New Vice President of North American Capital Sales for the HTG EdgeSeq Platform (NASDAQ:HTGM) www.publicnow.com - June 20 at 4:19 PM
	Broker Roundup For HTG Molecular Diagnostics, Inc. (HTGM) - Share Trading News (NASDAQ:HTGM) www.sharetrading.news - May 28 at 1:18 PM
	Edited Transcript of HTGM earnings conference call or presentation 12-May-16 8:30pm GMT (NASDAQ:HTGM) finance.yahoo.com - May 18 at 5:38 PM
	HTG Molecular Diagnostics Announces Immuno-Oncology Research Collaboration Agreement with Bristol-Myers Squibb (NASDAQ:HTGM) www.publicnow.com - May 12 at 5:27 PM
	HTG Molecular Diagnostics Reports First Quarter 2016 Results (NASDAQ:HTGM) www.publicnow.com - May 12 at 5:27 PM
	Q1 2016 HTG Molecular Diagnostics Inc Earnings Release - After Market Close (NASDAQ:HTGM) biz.yahoo.com - May 12 at 7:07 AM
	Don Hardison Joins the Board of Directors for HTG Molecular Diagnostics (NASDAQ:HTGM) www.publicnow.com - May 3 at 4:30 PM
	HTG Molecular Diagnostics to Hold 2016 First Quarter Financial Results Conference Call on May 12, 2016 (NASDAQ:HTGM) www.publicnow.com - May 2 at 4:20 PM
	HTG MOLECULAR DIAGNOSTICS, INC Files SEC form 8-K, Creation of a Direct Financial Obligation or an Obligation under a (NASDAQ:HTGM) biz.yahoo.com - March 31 at 4:07 PM
	HTG MOLECULAR DIAGNOSTICS, INC Financials (NASDAQ:HTGM) finance.yahoo.com - March 30 at 1:04 PM
	HTG MOLECULAR DIAGNOSTICS, INC Files SEC form 10-K, Annual Report (NASDAQ:HTGM) biz.yahoo.com - March 25 at 6:16 AM
	Edited Transcript of HTGM earnings conference call or presentation 24-Mar-16 8:30pm GMT (NASDAQ:HTGM) finance.yahoo.com - March 25 at 12:56 AM
	HTG Molecular Diagnostics Reports Fourth Quarter and Full Year 2015 Results (NASDAQ:HTGM) www.publicnow.com - March 24 at 4:16 PM
	Q4 2015 HTG Molecular Diagnostics Inc Earnings Release - After Market Close (NASDAQ:HTGM) biz.yahoo.com - March 24 at 7:07 AM
	HTG MOLECULAR DIAGNOSTICS, INC Files SEC form 8-K, Entry into a Material Definitive Agreement, Financial Statements a (NASDAQ:HTGM) biz.yahoo.com - March 21 at 4:34 PM
	HTG Molecular Diagnostics to Hold 2015 Fourth Quarter and Full Year Financial Results Conference Call on March 24, 2016 (NASDAQ:HTGM) finance.yahoo.com - March 15 at 4:05 PM
	Morning Buzz: HTG Molecular Diagnostics, Inc. (NASDAQ:HTGM), Comcast Corporation (NASDAQ:CMCSA ... - KC Register (NASDAQ:HTGM) www.kcregister.com - March 14 at 2:54 PM
	HTG Molecular Diagnostics, Inc. (HTGM) Analyst Updates - Risers & Fallers (NASDAQ:HTGM) www.risersandfallers.com - March 13 at 2:34 PM
	Analyst Coverage Updates – HTG Molecular Diagnostics, Inc. (HTGM) - Risers & Fallers (NASDAQ:HTGM) www.risersandfallers.com - March 9 at 2:38 PM
	Average Rating Update on HTG Molecular Diagnostics Inc (NASDAQ:HTGM) - Business Standard Tribune (NASDAQ:HTGM) www.standardtrib.com - March 9 at 2:38 PM
	HTG Molecular Diagnostics Inc (NASDAQ:HTGM) Analyst Rating & Update - WallStreet.org (NASDAQ:HTGM) www.wallstreet.org - March 8 at 2:33 PM
	Htg Molecular Diagnostics Incorporated (NASDAQ:HTGM) Shorts Decreased by 16.63% After Short Covering - Franklin Independent (NASDAQ:HTGM) www.franklinindependent.com - March 4 at 1:55 PM
	HTG Molecular Diagnostics, Inc. (HTGM) New Analyst Ratings - Share Trading News (NASDAQ:HTGM) www.sharetrading.news - March 3 at 2:21 PM
	HTG Molecular Diagnostics, Inc. (HTGM) Recent Analyst Updates - Risers & Fallers (NASDAQ:HTGM) www.risersandfallers.com - February 29 at 2:18 PM